Valuation is the primary weakness (avg 40/100). No single area scores well.
Broad-market heuristics · Not a buy/sell signal
Valuation and growth
Valuation
Growth
Above 30x, priced for sustained outperformance
Above 30x, cash flow yield is thin
5–10% CAGR, steady but not exceptional
2–5% CAGR, growing but slowly
Business Quality & Capital Allocation
Shrinking >2%, active buybacks
Modest contraction, within normal range
Net debt/FCF of 1.3x, somewhat elevated
15–20%, well above cost of capital
Johnson & Johnson (JNJ) quality: score, margins and returns
Johnson & Johnson (JNJ) scores 53/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 25.7% operating margins and 18.1% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Johnson & Johnson (JNJ) a high-quality business?+
Johnson & Johnson scores 53 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 25.7% operating margin and a 18.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.
What does Johnson & Johnson's quality score measure?+
Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from JNJ's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Johnson & Johnson scores well and where it falls behind.
What is Johnson & Johnson's return on invested capital (ROIC)?+
Johnson & Johnson earns about 18.1% on its invested capital, which is strong. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to JNJ's margins and growth on this scorecard to judge durability.
How profitable is Johnson & Johnson?+
Johnson & Johnson runs an operating margin of about 25.7% and a net margin of about 16.2%. Revenue has grown at roughly 2.7% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.
SourceQuality score computed from the 10-Q filed 15 Oct 2026, covering the period ending 27 Sept 2026, as reported to the SEC. Data last refreshed 22 Oct 2026. How this is calculated.
Fiscal year ends Jan. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.
Peers
Pharmaceutical Preparations · Pick stocks to compare with JNJ
Held by ETFs
JNJ is in 485 US ETFs. The largest of them, with JNJ's weight in each:
Spot a number that looks wrong? Check it in JNJ's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing JNJ
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.